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Localization of Phosphatidylinositol 4,5-Bisphosphate to Lipid Rafts
and Uroids in the Human Protozoan Parasite Entamoeba histolytica
Amrita B. Koushik,a Rhonda R. Powell,b Lesly A. Temesvarib
Department of Genetics and Biochemistry, Clemson University, Clemson, South Carolina, USAa; Department of Biological Sciences, Clemson University, Clemson, South
Carolina, USAb
Entamoeba histolytica is an intestinal protozoan parasite and is the causative agent of amoebiasis. During invasive infection,
highly motile amoebae destroy the colonic epithelium, enter the blood circulation, and disseminate to other organs such as liver,
causing liver abscess. Motility is a key factor in E. histolytica pathogenesis, and this process relies on a dynamic actomyosin cyto-
skeleton. In other systems, phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2] is known to regulate a wide variety of cellular
functions, including signal transduction, actin remodeling, and cell motility. Little is known about the role of PI(4,5)P2 in E. his-
tolytica pathogenicity. In this study, we demonstrate that PI(4,5)P2 is localized to cholesterol-rich microdomains, lipid rafts, and
the actin-rich fractions of the E. histolyticamembrane. Microscopy revealed that the trailing edge of polarized trophozoites,
uroids, are highly enriched in lipid rafts and their constituent lipid, PI(4,5)P2. Polarization and enrichment of uroids and rafts
with PI(4,5)P2 were enhanced upon treatment of E. histolytica cells with cholesterol. Exposure to cholesterol also increased in-
tracellular calcium, which is a downstream effector of PI(4,5)P2, with a concomitant increase in motility. Together, our data sug-
gest that in E. histolytica, PI(4,5)P2 may signal from lipid rafts and cholesterol may play a role in triggering PI(4,5)P2-mediated
signaling to enhance the motility of this pathogen.
The intestinal parasite Entamoeba histolytica is known to causeamoebic dysentery and liver abscess. E. histolytica enters the
human host via contaminated food or water as an environmen-
tally stable cyst. Excystation leads to the release of trophozoites
in the small intestine, which colonize the bowel lumen. From here,
the parasite can enter two non-mutually exclusive routes of infec-
tion, noninvasive or invasive disease (reviewed in reference 1). In
the noninvasive mode, the trophozoite encysts and exits the host,
whereas in the invasive mode, the parasite adheres to and destroys
the colonic epithelium and enters the circulatory system. This
results in extraintestinal infection, of which amoebic liver abscess
(ALA) is the most common manifestation. Motility is a key viru-
lence function that enables this parasite to cause extraintestinal
infection (2).
Motile amoebae display a polarized morphology with a pseu-
dopod at the leading edge and a uroid (also referred to as a uropod
in other eukaryotic cells) at the trailing edge. A key feature of a
polarized cell is the differential distribution of proteins and lipids,
including cell surface receptors, signaling molecules, and cytoskel-
etal elements. For example, the pseudopod of E. histolytica is en-
riched in F actin, myosin IB (3, 4), and signaling molecules like
phosphatidylinositol-3,4,5-trisphosphate [PI(3,4,5)P3] (5), while
the uroid is enriched in myosin II and signaling molecules, includ-
ing an important heterotrimeric adhesin, the galactose/N-acetyl-
galactosamine (Gal/GalNAc) lectin (6), F actin, and various actin-
binding proteins (7–9). Such spatial asymmetry helps the cells to
generate the necessary forces that are required for migration. For
example, polymerization of actin at the leading edge facilitates
pseudopod extension. Concurrently, adhesion molecules estab-
lish new focal contacts with the substrate, while activation of my-
osin II motors generates the contractile force required for the de-
tachment of existing focal adhesions at the uroids. Together, these
activities result in a net forward movement of the cell body. Con-
sequently, motility in this pathogen has been attributed to its
highly dynamic actomyosin cytoskeleton, which promotes the
rapid morphological changes required for cell movement (re-
viewed in reference 10).
Phosphoinositides act as links that connect the actomyosin cy-
toskeleton to the plasma membrane. In other systems, phospha-
tidylinositol 4,5-bisphosphate [PI(4,5)P2] regulates the strength
of the interaction between the cytoskeleton and the plasma mem-
brane, which is required for maintaining cell shape and integrity
(11). PI(4,5)P2 belongs to a group of phosphorylated phosphoi-
nositides that act as second messenger molecules by binding to
and modulating the activity of various cytoskeleton remodeling
proteins. Furthermore, other lipid second messenger molecules
can be generated from PI(4,5)P2. For instance, the pleckstrin ho-
mology (PH) domain of phospholipase C delta 1 (PLCD1) can
bind PI(4,5)P2. PLCD1 hydrolyzes PI(4,5)P2 to yield inositol
triphosphate (IP3) and diacylglycerol (DAG) (12, 13). While IP3
stimulates an increase in intracellular calcium (Ca2) levels (re-
viewed in references 14 and 15), DAG activates protein kinase C
(PKC) (reviewed in reference 16). PI(4,5)P2 can be phosphory-
lated by phosphoinositide 3-kinases (PI3Ks) to yield yet another
signaling molecule, PI(3,4,5)P3 (reviewed in reference 17). All of
these signaling molecules, PI(4,5)P2, PI(3,4,5)P3, IP3, DAG, and
Ca2, can interact with other effector proteins to trigger down-
stream signaling events.
In mammalian cells, PI(4,5)P2 is localized to lipid rafts (18–
20). Rafts are specialized membrane microdomains that are cho-
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lesterol and sphingolipid rich and are known to organize signaling
molecules that participate in a variety of cellular functions, includ-
ing cell polarization (21, 22), endocytosis (reviewed in reference
23), secretion (reviewed in reference 24), and adhesion (25). Pre-
viously, E. histolytica was shown to possess lipid rafts that regulate
parasite-host interaction (26, 27). Disruption of rafts with choles-
terol-binding agents like methyl--cyclodextrin (MCD) inhibits
adhesion of E. histolytica to host cells (26) and host extracellular
matrix components (27). On the other hand, cholesterol loading
of amoebic membranes results in enhanced adhesion to host cell
monolayers, as well as cocompartmentalization of the three sub-
units of the Gal/GalNAc lectin in lipid rafts (28).
Whether PI(4,5)P2 localizes to rafts in E. histolytica has not
been previously studied. Therefore, in the current study, we de-
veloped a PI(4,5)P2 biosensor and utilized antibody to PI(4,5)P2
to study its subcellular and submembrane localization, respec-
tively. We demonstrate that PI(4,5)P2 localizes to rafts in E. histo-
lytica and may signal from the raft membrane domain to regulate
cell motility.
MATERIALS AND METHODS
Strains and culture conditions. Entamoeba histolytica trophozoites
(strain HM-1:1MSS) were cultured axenically in TYI-S-33 medium (29)
in 15-ml glass screw-cap tubes at 37°C.
Exposure to cholesterol or methyl--cyclodextrin. The source of
cholesterol used was a bovine cholesterol concentrate (Creative Labora-
tory Products, Inc., Indianapolis, IN). In all cases, to control for extracel-
lular sources of cholesterol, trophozoites were incubated in serum-free
medium (TYI-S-33) for 30 min at 37°C prior to experimentation. After
serum starvation, trophozoites were incubated in serum-free medium
supplemented with 0 to 3 mg/ml cholesterol or 50 mM methyl--cyclo-
dextrin (MCD; Sigma-Aldrich, St. Louis, MO) for 15 or 60 min at 37°C.
Cells treated with 0 mg/ml cholesterol represented the untreated controls
for all experiments.
Lipid raft isolation, lipid extraction, and lipid dot blots. Isolation of
a Triton X-100-resistant membrane and resolution of a detergent-resis-
tant membrane (DRM) by sucrose gradient density centrifugation were
carried out as previously described (26). Extraction of lipids from the
sucrose gradient membrane fractions was carried out as described previ-
ously (30). Briefly, methanol–12.1 N HCl (10:1) was added to each frac-
tion at a volumetric ratio of 1:1, and chloroform was added at a volumetric
ratio of 2:1 (solvent-membrane fraction) to facilitate phase separation.
The organic phase was subsequently extracted with the addition of meth-
anol–1 N HCl (1:1) at a volumetric ratio of 1:1. The organic phase was
vacuum dried, and the pellets were used for lipid dot blot analysis. Spe-
cifically, lipids were spotted onto a Hybond-C nitrocellulose membrane.
The membrane was blocked in 1.5% (wt/vol) fatty acid-free bovine serum
albumin (BSA) at room temperature for 1 h and probed with mouse
anti-PI(4,5)P2 antibody (1:1,000 dilution; Abcam, Cambridge, MA), fol-
lowed by incubation with secondary antibody, peroxidase-conjugated
goat anti-mouse IgG (1:2,000 dilution; Cappel, ICN Pharmaceuticals,
Costa Mesa, CA). Immunoblots were visualized using an enhanced
chemiluminescence Western blotting detection system (Pierce Biotech-
nology, Rockford, IL) according to the manufacturer’s instructions. Semi-
quantitative densitometric analyses of immunoblots were performed us-
ing ImageJ software (version 1.42q; National Institutes of Health,
Bethesda, MD). The net densitometry values were corrected to reflect the
differences in membrane fraction volume. Whole-cell lipid extraction and
lipid dot blot analyses were performed as previously described (31).
Generation of GST-tagged PHPLCD1 recombinant protein. The
cDNA encoding the PH domain from PLCD1 (PHPLCD1) was amplified
from pEGFP-N1 (SignaGen Laboratories, Gaithersburg, MD) by PCR
using the following primer pair: 5=-GGAATTCATGGACTCGGGCCGG
GAC-3= and 5=-GGTCGACTCCTTCAGGAAGTTCTGCAG-3=. The re-
sulting PCR product was cloned into the pCR2.1-TOPO plasmid (Invit-
rogen, Carlsbad, CA). The DNA sequence encoding PHPLCD1 was excised
from pCR2.1-TOPO using EcoRI and SalI endonucleases and was ligated
into the polylinker region downstream of and in frame with the sequence
encoding glutathione S-transferase (GST) in the pGEX-5X-1 expression
vector (Amersham Biosciences, Piscataway, NJ). The authenticity of the
DNA construct was confirmed using restriction enzyme analysis and se-
quencing. Recombinant GST and GST-PHPLCD1 proteins were obtained
by expression in Escherichia coli BL21 (Amersham, Piscataway, NJ) ac-
cording to the manufacturer’s protocol. To assess the purity of the eluted
proteins, SDS-PAGE and silver staining were carried out as previously
described (32). To validate the GST tag, Western blotting was performed
as described previously (33) using an anti-GST antibody (Chemicon, Te-
mecula, CA) at a dilution of 1:10,000.
Protein-lipid overlay assay. A protein-lipid overlay assay was carried
out to assess the PI(4,5)P2 binding capability of the GST-PH
PLCD1 fusion
protein as described previously (34). Briefly, 1.6 to 100 pmol of phosphoi-
nositides (Echelon Biosciences Inc., Salt Lake City, UT), including phos-
phatidylinositol 3-phosphate (PI3P), phosphatidylinositol 4-phosphate
(PI4P), phosphatidylinositol 5-phosphate (PI5P), phosphatidylinositol
3,4-bisphosphate [PI(3,4)P2], phosphatidylinositol 3,5-bisphosphate
[PI(3,5)P2], phosphatidylinositol 4,5-bisphosphate [PI(4,5)P2], and
phosphatidylinositol 3,4,5-triphosphate [PI(3,4,5)P3], was spotted on a
Hybond-C nitrocellulose membrane. The membrane was dried for 1 h at
room temperature and incubated in blocking buffer containing 2% (wt/
vol) fatty acid-free BSA in Tris-buffered saline (TBS)–Tween (50 mM
Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% [vol/vol] Tween 20) at room tem-
perature for 1 h. The membrane was incubated overnight at 4°C in block-
ing buffer containing 0.2g/ml of either GST or GST-PHPLCD1, washed in
TBS-Tween, and incubated in polyclonal anti-GST antibody (1:10,000
dilution) in blocking buffer for 1 h. The membrane was washed, incubated
in horseradish peroxidase (HRP)–anti-rabbit IgG (1:5,000 dilution) in
TBS-Tween for 1 h, and then washed and developed as described previ-
ously (33).
We also tested the ability of GST or GST-PHPLCD1 to bindE. histolytica
cell extracts. Whole-cell protein extracts of trophozoites (5 105 and 1
105 cells) were resolved by SDS-PAGE and electroblotted onto a nitrocel-
lulose membrane. The membrane was washed twice with distilled water
and dried for 1 h at room temperature. Serial dilutions of PI(4,5)P2 were
spotted on one edge of the same membrane, which served as a positive
control for binding of the probe. The membrane was dried and incubated
with blocking buffer containing 2% (wt/vol) fatty acid-free BSA in TBS-
Tween (50 mM Tris-HCl, pH 7.5, 150 mM NaCl, 0.1% [vol/vol] Tween
20), followed by incubation with 0.2 g/ml of either GST or GST-
PHPLCD1 probes in the blocking buffer, as described above. The mem-
brane was washed in TBS-Tween and incubated in polyclonal anti-GST
antibody (1:10,000 dilution) in blocking buffer, followed by incubation
with HRP–anti-rabbit IgG (1:5,000 dilution) in TBS-Tween, and then
washed and developed as described previously (33). As a positive control
for protein transfer, the membrane was incubated in anti-actin monoclo-
nal antibody (1:2,500 dilution; Abcam) for 1 h. The membrane was
washed, incubated in HRP–anti-mouse IgG (1:2,000 dilution) in TBS-
Tween for 1 h, and then washed and developed as described previously
(33).
Biosensor staining and fluorescence microscopy. For fluorescence
microscopy, E. histolytica trophozoites were plated on a chambered cover
glass slide system (Lab-Tek, Christchurch, New Zealand) and fixed with
4% (vol/vol) paraformaldehyde overnight at 37°C. Cells were washed in
phosphate-buffered saline (PBS), incubated in 50 mM NH4Cl in PBS for
15 min, and then permeabilized with 0.05% (wt/vol in PBS) saponin for
10 min as previously described (35). All subsequent buffers contained
0.05% (wt/vol in PBS) saponin. This regimen preserves the cellular mor-
phology and permeabilizes cells without removing phosphoinositides
from the plasma membrane (5, 35). Cells were blocked with 10% (vol/vol)
fetal bovine serum (FBS)–PBS and stained with approximately 10 g/ml
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of either affinity-purified GST or GST-PHPLCD1, followed by staining with
Alexa Fluor 488-conjugated rabbit anti-GST antibody (1:2,000; Invitro-
gen) or Texas Red-conjugated goat anti-GST antibody (1:1,000; Rockland
Immunochemicals, Gilbertsville, PA), as described previously (35).
Stained cells were viewed using a Nikon Eclipse TI-E spectral confocal
microscope (Nikon Instruments Inc., Lewisville, TX) or an LSM510 con-
focal microscope (Carl Zeiss MicroImaging, Thornwood, NY). Images
were analyzed using Nikon NIS Elements or LSM Image Browser soft-
ware, respectively. To assess the effect of cholesterol on localization of
PI(4,5)P2, cells were exposed to either 0 or 3 mg/ml cholesterol for 1 h and
then fixed and stained as described above.
For lipid raft staining, E. histolytica trophozoites were fixed with 4%
(vol/vol) paraformaldehyde overnight at 37°C. Dialkyindocarbocyanine
(DiIC16; Invitrogen) staining of lipid rafts was carried out as described
previously (27).
To determine if PI(4,5)P2 and lipid rafts localized to uroids, capping
was induced by incubation of amoebae with Alexa Fluor 488-conjugated
concanavalin A (ConA; Invitrogen) for 1 h on ice, followed by incubation
on cover glass chambered slides for 15 min at 37°C as described previously
(6). PI(4,5)P2 or lipid raft staining was carried out as described above.
Measurement of motility. To test the effect of cholesterol on parasite
motility, a motility assay was employed according to the methods of Zaki
et al. (36). Briefly, cells were serum starved for 30 min at 37°C and exposed
to a range of cholesterol concentrations (0 to 3 mg/ml) in serum-free
medium for 30 min at 37°C. Eight milliliters of complete TYI-S-33 me-
dium supplemented with 0.75% (wt/vol) agarose was poured into 60-mm
petri dishes and allowed to solidify at room temperature. A trough (2
by 30 mm) was cut into the solidified medium to serve as the motility
chamber. Following exposure to cholesterol, trophozoites (5  105)
were placed in the trough of the motility chamber. A coverslip (22 by
40 mm) was placed over the trough and the plate was incubated at 37°C
for 3 h in 5% CO2. Images were captured using confocal microscopy.
The migration distance was measured using Zeiss LSM510 image anal-
ysis software.
Measurement of intracellular Ca2 levels. To measure the effect of
cholesterol treatment on intracellular Ca2 levels, a Ca2 assay was em-
ployed as described previously (31). Briefly, cells were incubated in se-
rum-free medium supplemented with the fluorescent Ca2 indicator
Fluo-4/AM (Invitrogen) or dimethyl sulfoxide (DMSO; diluent control)
for 30 min at 37°C. Then, cells were incubated with a range of concentra-
tions of cholesterol (0 to 3 mg/ml) for either 15 min or 1 h at 37°C.
Subsequently, 1  105 trophozoites were pipetted into the wells of an
uncoated 96-well plate, and after 5 min the plates were transferred to a
fluorescence microplate reader for 30 min. To account for the background
fluorescence, the fluorescence values for cells incubated in DMSO were
subtracted from the fluorescence values for cells incubated in Fluo-4/AM.
The fluorescence value of the untreated control cells at the 35-min time
point was arbitrarily set equal to 100%, and the values at other time points
were reported as a percentage of this value.
Statistical analyses. All values are given as means  standard devia-
tions (SDs) of at least 3 trials. To compare means, statistical analyses were
performed using GraphPad Instat v.3 software with an unpaired t test,
Welch corrected (two-tail P value), or with one-way analysis of variance
(ANOVA) and a Tukey-Kramer multiple-comparison test. In all cases, P
values of less than 0.001 were considered highly statistically significant,
while P values of less than 0.01 or 0.05 were considered statistically signif-
icant.
RESULTS
PI(4,5)P2 compartmentalizes in lipid rafts and actin-rich pellet
fractions of the DRM in E. histolytica. In mammalian cells,
PI(4,5)P2 has been shown to localize to lipid rafts (18, 19). There-
fore, we determined if E. histolytica exhibits similar compartmen-
talization of PI(4,5)P2. The detergent-resistant membrane
(DRM), which consists of lipid rafts and the actin-rich membrane,
was isolated as described previously (26). Sucrose gradient density
centrifugation was used to resolve these two membrane types.
Total phosphoinositides were extracted from each of the gradient
fractions and subjected to a lipid dot blot analysis using antibodies
to PI(4,5)P2 (Fig. 1A). We previously demonstrated that mem-
brane fractions 9 to 14 possess high levels of cholesterol and con-
tain lipid rafts (31). Less buoyant fractions (fractions 17 to 19) and
the pellet fraction (fraction 20) are actin rich (26, 28, 31). Similar
to the enrichment seen in mammalian cells, we observed an en-
richment of PI(4,5)P2 in lipid rafts (fractions 9 to 14) (Fig. 1A and
B). However, the actin-rich pellet fraction also possessed high lev-
els of this phospholipid (Fig. 1A and B). Thus, there may be two
pools of PI(4,5)P2 in E. histolytica, one pool in lipid rafts and
another pool interacting directly with the actin cytoskeleton.
However, we cannot rule out the possibility that PI(4,5)P2 in rafts
also interacts with the actin cytoskeleton in live cells.
Exposure to cholesterol increases levels of PI(4,5)P2 in the
DRM. Previous studies in mammalian cells have revealed that the
level of membrane cholesterol influences the localization of
PI(4,5)P2 in the DRM (18). Therefore, we tested the effect of ex-
posure to cholesterol or to the cholesterol-sequestering agent
MCD on the localization and overall levels of PI(4,5)P2 in E.
histolytica trophozoites. On average, cells treated with 0.05 mg/ml
cholesterol displayed a slight increase in PI(4,5)P2 levels in the
lipid raft fractions compared to control untreated cells; however,
there was no difference in the level of PI(4,5)P2 in the total DRM
(Fig. 2A to C). The most dramatic changes in the level of PI(4,5)P2
in the total DRM were observed when the cells were exposed to
0.75 and 3 mg/ml cholesterol, with an approximately 60% in-
crease (Fig. 2A). In contrast, MCD caused a 56% decrease in the
FIG 1 PI(4,5)P2 compartmentalizes in lipid rafts and actin-rich pellet frac-
tions. The DRM was isolated from Entamoeba histolytica trophozoites and
subjected to sucrose gradient density fractionation. PI(4,5)P2 was extracted
from these fractions, and lipid dot blots were performed using antibodies
specific to PI(4,5)P2. (A) A representative blot is shown. Cells displayed
PI(4,5)P2 enrichment in lipid raft fractions (fractions 9 to 14) and in an actin-
rich pellet fraction (fraction 20 P). (B) Semiquantitative scanning densitome-
try was used to analyze the distribution of PI(4,5)P2 in membrane fractions,
correcting for the difference in the starting volume of each membrane fraction.
The total level of PI(4,5)P2 in the DRM was calculated, and the percentage of
PI(4,5)P2 in each fraction ( SD; n 3) is presented.
Localization of PI(4,5)P2 in E. histolytica
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level of PI(4,5)P2 from that in the total DRM (Fig. 2A). Further-
more, treatment with 0.75 and 3 mg/ml cholesterol increased the
level of PI(4,5)P2 specifically in lipid rafts (Fig. 2B and C). To
determine if these changes were due to overall increases or de-
creases in PI(4,5)P2, we also quantified total PI(4,5)P2 in whole
cells. We did not find a significant difference in the total cellular
level of PI(4,5)P2 after cholesterol or MCD exposure (Fig. 2D).
Thus, PI(4,5)P2 may be moving between membrane compart-
ments in a cholesterol-dependent manner. However, we cannot
rule out the possibility that there is a rapid turnover of PI(4,5)P2,
where continuous synthesis and hydrolysis maintain a constant
total level.
A GST-tagged PH probe reveals localization of PI(4,5)P2 to
plasma membrane and uroids. We have previously determined
the subcellular localization of PI3P (35) and PI(3,4,5)P3 (5) using
a GST-tagged FYVE finger domain and a GST-tagged pleckstrin
homology (PH) domain of Bruton’s tyrosine kinase (PHBTK), re-
spectively. We used a similar approach to determine the subcellu-
lar localization of PI(4,5)P2 using a recombinant GST-tagged ver-
sion of the PH domain from PLCD1 (PHPLCD1). This protein
domain has been shown to specifically bind PI(4,5)P2, and the
GST-tagged chimera has been used to study the localization of
PI(4,5)P2 in mammalian cells (37).
Recombinant GST (control) and GST-PHPLCD1 were ex-
pressed in bacteria and affinity purified. SDS-PAGE demonstrated
that the proteins were 28 kDa and 48 kDa in size, which are con-
sistent with the predicted sizes of GST and GST-PHPLCD1, respec-
tively (Fig. 3A). The authenticity of the GST tag was confirmed by
Western blotting with antibodies specific for GST (Fig. 3B). To
test the binding specificity of GST-PHPLCD1, we employed a pro-
tein-lipid overlay assay as described previously (34, 37). The probe
bound to PI(4,5)P2 in a dose-dependent manner and did not dis-
play any significant capacity for binding to other related phos-
phoinositides (Fig. 3C). GST alone (control) did not bind any of
FIG 2 Exposure to cholesterol increases the levels of PI(4,5)P2 in the DRM and specifically in lipid raft fractions. Trophozoites were serum starved and exposed
to cholesterol (0 to 3 mg/ml) or the cholesterol-depleting agent MCD. Cells treated with no cholesterol (0 mg/ml) served as the untreated control. (A to C) The
DRM was isolated and subjected to sucrose gradient density fractionation. PI(4,5)P2 was extracted from these fractions, and lipid dot blots were performed using
antibodies specific to PI(4,5)P2. Levels of PI(4,5)P2 were analyzed by semiquantitative scanning densitometry. In all cases, values were corrected for differences
in starting volumes. (A) The total level of PI(4,5)P2 in the DRM was calculated and reported as a percentage of that for the untreated control. Cells treated with
cholesterol (0.75 or 3 mg/ml) and MCD displayed an approximately 60% increase and 56% decrease in PI(4,5)P2 in the total DRM, respectively, compared to
the levels for the control (n 3) (*, P 0.5; **, P 0.01). (B) A representative lipid dot blot of the sucrose gradient density fraction is shown. Cells treated with
cholesterol (0.75 and 3 mg/ml) displayed enhanced enrichment of PI(4,5)P2 in lipid rafts (fractions 9 to 14) compared to the control, while MCD-treated cells
showed a decrease in PI(4,5)P2 from all fractions of the DRM. (C) The data represent the percentage of PI(4,5)P2 in each fraction compared to the level of
PI(4,5)P2 in the total DRM of the untreated control cells ( SD; n 3). (D) Phosphoinositides were extracted from whole-cell lysates, and PI(4,5)P2 levels were
measured using dot blots with antibodies specific to PI(4,5)P2. The level of PI(4,5)P2 for each treatment was quantified by scanning densitometry and reported
as a percentage of the level for the untreated control. The total cellular PI(4,5)P2 level remained unchanged upon treatment with cholesterol or MCD. Data are
the means SDs for3 independent experiments.
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the phosphoinositides (data not shown). We also determined if
the probes bound nonspecifically toE. histolyticaproteins. Whole-
cell protein extract was resolved by SDS-PAGE, electroblotted
onto a nitrocellulose membrane, and decorated with GST or GST-
PHPLCD1. Neither GST nor GST-PHPLCD1 displayed binding to E.
histolytica proteins (Fig. 3D). Together, these data suggest that the
GST-PHPLCD1 probe is highly specific for PI(4,5)P2 and does not
cross-react with other cellular lipids or proteins. Therefore, it
could be utilized for subcellular localization of PI(4,5)P2.
E. histolytica trophozoites were fixed, permeabilized, and
stained with GST or GST-PHPLCD1, followed by staining with a
fluorescence-labeled anti-GST antibody. Confocal microscopy re-
vealed that cells stained with control GST exhibited minimal flu-
orescence (Fig. 4A and D). In contrast, the GST-PHPLCD1 probe
uniformly decorated the plasma membrane, giving most cells a
ring-like appearance (Fig. 4B and E). This was not surprising, as
PI(4,5)P2 is known to account for 1% of plasma membrane phos-
pholipids and99% of all doubly phosphorylated phospholipids
and is maintained at a high steady-state level in mammalian cells
(reviewed in references 17, 20, and 38). Interestingly, in some cells,
PI(4,5)P2 was also enriched on one side of the cell, opposite ap-
parent forming pseudopods (Fig. 4C and F).
FIG 3 The purified GST-PHPLCD1 biosensor binds with high affinity to PI(4,5)P2. (A) SDS-PAGE and silver staining of GST and GST-PH
PLCD1 fusion proteins
after affinity purification. The molecular mass markers are shown. (B) Western blot analysis of purified GST and GST-PHPLCD1 using anti-GST antibody. (C)
Serial dilutions (100 to 1.6 pmol) of the indicated phosphoinositides were spotted onto a nitrocellulose membrane and incubated with 0.2 g/ml of GST-
PHPLCD1. Binding of the protein was detected with anti-GST antibodies. The probe exhibited binding specificity to PI(4,5)P2 alone. (D) Whole-trophozoite
extracts (5 105 and 1 105 cells) were resolved by SDS-PAGE and electroblotted onto a Hybond-C nitrocellulose membrane. Individual lanes of lysate were
decorated with GST (i), GST-PHPLCD1 (ii), or anti-actin antibody (positive control for protein transfer) (iii). (ii) As an additional control for binding of the
GST-PHPLCD1 probe, the membrane was washed after the protein transfer and serial dilutions of PI(4,5)P2 were spotted on the same membrane and incubated
with GST-PHPLCD1. Binding of the probes was detected with anti-GST antibodies. Neither GST nor GST-PHPLCD1 probe bound to the whole-cell protein extract,
further supporting the specificity of the probe.
FIG 4 The PI(4,5)P2 biosensor GST-PH
PLCD1 decorates the plasma membrane of E. histolytica. Trophozoites were stained with GST or GST-PHPLCD1 and
fluorescent anti-GST antibody, and immunofluorescence confocal microscopy was performed. (A) Cells stained with the control, GST, exhibited minimal
staining. (B) GST-PHPLCD1 uniformly decorated the plasma membrane of the trophozoites, giving the cells a ring-like appearance. (C) In some instances, there
was an enrichment of GST-PHPLCD1staining on one edge of the cell (arrow), opposite an apparent pseudopod (arrowhead). (D to F) The differential interference
contrast (DIC) images corresponding to the images in panels A to C, respectively, are shown.
Localization of PI(4,5)P2 in E. histolytica
June 2013 Volume 81 Number 6 iai.asm.org 2149
Studies in other systems (18) and our biochemical analysis
(Fig. 2A to C) indicated that cholesterol levels impact the localiza-
tion of PI(4,5)P2 in the DRM. Therefore, we wanted to determine
the subcellular localization of PI(4,5)P2 in whole cells after expo-
sure to cholesterol or after cholesterol depletion. Interestingly,
there was an increase in the number of cells displaying PI(4,5)P2
localization at one edge upon cholesterol treatment (Fig. 5B and
E) compared to the number for the untreated control (Fig. 5A and
D). Image analysis revealed that there was a 3.4-fold increase in the
number of cells displaying this morphology after cholesterol treat-
ment compared to the number of control cells (Fig. 5G). In con-
trast, cholesterol depletion with MCD disrupted the localization
of PI(4,5)P2 at the plasma membrane, in that it was observed in
the interior of the cell (Fig. 5C and F). This suggested a require-
ment of cholesterol richness for proper localization of PI(4,5)P2 to
the plasma membrane.
Cholesterol treatment enhances motility. In other systems,
PI(4,5)P2 plays an essential role in cell motility. Since PI(4,5)P2
became asymmetrically distributed after exposure to cholesterol
(Fig. 5B and E) and since asymmetry is a hallmark of motile cells,
we hypothesized that exposure to cholesterol was enhancing mo-
tility. To test this, we utilized a previously published under-agar
motility assay (36) to determine the effect of cholesterol exposure
on cell movement. Upon exposure to cholesterol, the ability of the
trophozoites to move out of the wells increased significantly in a
dose-dependent fashion (Fig. 6A). After exposure to cholesterol,
not only did cells traverse longer distances but also there was an
apparent increase in the number of motile cells (Fig. 6B and C).
This suggests a possible role for cholesterol in mediating motility
in E. histolytica.
PI(4,5)P2 localizes to uroids in ConA-capped E. histolytica
cells. In apparently polarized cells, PI(4,5)P2 appeared to be en-
riched on one edge opposite that of the forming pseudopods. This
could represent localization of PI(4,5)P2 to the trailing edge
(uroid). Therefore, we employed a polyvalent ligand, ConA,
which is known to interact with and cap cell surface receptors at
the trailing edge of the trophozoites (39). Thus, labeled ConA
serves as a uroid marker. PI(4,5)P2 colocalized with fluorescent
ConA in uroids (Fig. 7A to D) and with patches of ConA in tro-
phozoites in which capping was initiated but was not complete
(data not shown).
FIG 5 Treatment with cholesterol enhances the number of cells displaying PI(4,5)P2 enrichment at the edge opposite the forming pseudopod. Trophozoites were
serum starved and exposed to either 0 mg/ml cholesterol (control), 3 mg/ml cholesterol, or the lipid raft-disrupting agent MCD. Cells were stained with
GST-PHPLCD1 and fluorescent anti-GST antibody, and immunofluorescence confocal microscopy was performed. (A and B) Cholesterol-treated cells displayed
an increased PI(4,5)P2 localization on one edge of the cell compared to untreated control cells. (C) In MCD-treated cells, PI(4,5)P2 staining was no longer
confined to the plasma membrane. (D to F) The DIC images corresponding to the images in panels A to C, respectively, are shown. (G) The percentage of
apparently polarized cells in control cells or after cholesterol treatment was quantified by visually scoring cells at20 magnification. There was a 3.4-fold increase
in the number of cells displaying PI(4,5)P2 localization on one edge after cholesterol treatment compared to the number for untreated control cells. Data are the
means SDs of 3 independent experiments (***, P 0.001).
FIG 6 Exposure to cholesterol enhances motility in E. histolytica cells. E. histo-
lytica trophozoites were serum starved and exposed to 0 to 3 mg/ml cholesterol. A
motility assay was performed, and images were captured using confocal micros-
copy. The distance migrated by trophozoites was measured. (A) Trophozoites
exhibited a dose-dependent and statistically significant increase in motility after
exposure to cholesterol (**, P  0.01; ***, P  0.001). The data represent the
means  SDs from 3 independent experiments. (B and C) Cholesterol treat-
ment also increased the number of motile cells compared to the number of un-
treated control cells entering the agar. Representative10 magnification fields of
control cells and cells treated with 3 mg/ml cholesterol are shown.
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Lipid rafts localize to uroids. Since our biochemical analysis
demonstrated that lipid rafts were enriched in PI(4,5)P2 and since
microscopy revealed that PI(4,5)P2 localized to uroids, we wanted
to determine if, like in mammalian cells (40), the uroids of E.
histolytica were enriched in lipid rafts. Therefore, we employed a
lipid raft stain, DiIC16, on fixed E. histolytica trophozoites as pre-
viously described (27). Cells with no apparent pseudopod forma-
tion (nonpolarized) displayed a uniform plasma membrane raft
staining (Fig. 8A and B), whereas apparently polarized cells also
showed an enrichment of raft staining at one edge opposite the
forming pseudopod (Fig. 8C and D). Colocalization of DiIC16
with ConA revealed that the uroids were indeed enriched in lipid
rafts (Fig. 8E to H). Similar to the results seen for PI(4,5)P2 stain-
ing, trophozoites with incomplete uroid formation exhibited
DiIC16 staining that colocalized with lateral patches of ConA (data
not shown).
Cholesterol treatment enhances intracellular Ca2 levels in
E. histolytica. In other systems, PLCD1 hydrolyzes PI(4,5)P2 into
IP3 and DAG, which facilitates Ca
2 signaling (13, 41). Since
PLCD1 also localizes to rafts (42), it is reasonable to hypothesize
that the accumulation of PI(4,5)P2 in rafts after cholesterol treat-
ment might lead to an increase in intracellular Ca2. Therefore,
we measured intracellular Ca2 levels after cholesterol treatment
using a previously published protocol (31). Several studies have
demonstrated that bona fide ligands of E. histolytica, such as col-
lagen and fibronectin themselves, induce signaling leading to in-
FIG 7 Fluorescence confocal microscopy of ConA-capped E. histolytica reveals localization of PI(4,5)P2 to uroids. (A to D) Trophozoites were incubated with
fluorescein isothiocyanate-ConA (green) for 1 h on ice, followed by incubation at 37°C for 15 min to initiate uroid formation. Cells were fixed and stained with
GST-PHPLCD1 and anti-GST antibody (red).
FIG 8 Fluorescence confocal microscopy of ConA-capped E. histolytica reveals localization of lipid rafts to uroids. The lipid raft localizes to uroids in E.
histolytica. (A to D) Trophozoites were fixed and stained with the lipid raft marker DiIC16. Nonpolarized cells displayed uniform plasma membrane raft staining,
while apparent polarized cells exhibited an enriched raft staining on one edge (arrowheads) opposite the pseudopod (arrows). (E to H) E. histolytica trophozoites
were incubated with fluorescein isothiocyanate-ConA (green) for 1 h on ice, followed by incubation at 37°C for 15 min to initiate uroid formation. Cells were
fixed and stained with the raft marker DiIC16 (red). There was a colocalization of ConA and DiIC16 staining at the uroid of E. histolytica, further supporting the
finding that lipid rafts are enriched at uroids in polarized cells.
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creased intracellular Ca2 (31, 43). Therefore, to test the effect of
cholesterol alone on intracellular Ca2 levels, we utilized un-
coated 96-well plates for our studies. After 1 h of pretreatment
with cholesterol, we observed a significant dose-dependent in-
crease in Ca2 (Fig. 9A). Since signaling events take place imme-
diately following stimulation, we also tested a shorter time of ex-
posure to cholesterol. After 15 min of pretreatment with 0.75 and
3 mg/ml cholesterol, we observed similar increases in Ca2, of
which some were statistically significant (Fig. 9B). Together, these
data indicate the possibility of a cholesterol-dependent, PI(4,5)P2-
mediated rise in intracellular Ca2 levels.
DISCUSSION
This study represents the first analysis of the submembrane local-
ization of PI(4,5)P2 in E. histolytica. Biochemical analyses showed
that PI(4,5)P2 is compartmentalized in lipid raft and actin-rich
pellet fractions of the DRM. Microscopy demonstrated that
PI(4,5)P2 uniformly decorated the plasma membrane in a major-
ity of the cells but also colocalized with lipid rafts at the uroids in
polarized cells. The connection between PI(4,5)P2 and rafts in E.
histolytica was supported by our observations that cholesterol
treatment increased the level of PI(4,5)P2 in the DRM, lipid rafts,
and raft-rich uroids and that MCD depleted the DRM and
plasma membrane of PI(4,5)P2. Finally, treatment with choles-
terol resulted in an increase in intracellular Ca2 [a downstream
effector of PI(4,5)P2] and a concomitant increase in motility.
Therefore, in E. histolytica, PI(4,5)P2 may signal from rafts and
cholesterol may play a role in triggering PI(4,5)P2-dependent sig-
naling.
Various studies have supported the existence of different cel-
lular pools of PI(4,5)P2 to explain the complex roles of PI(4,5)P2
in cells (reviewed in reference 38). In E. histolytica, we observed
compartmentalization of PI(4,5)P2 in lipid rafts as well as in the
actin-rich pellet fraction at steady state. We also showed that ex-
posure to cholesterol resulted in enrichment of PI(4,5)P2 in the
DRM and, specifically, in lipid rafts without an increase in the
total cellular level of PI(4,5)P2. One explanation for this is that
PI(4,5)P2 translocates between membrane subcompartments in a
cholesterol-dependent fashion. The parasite likely encounters dif-
ferent extracellular cholesterol levels depending on the location in
the human host (e.g., liver versus intestine). Therefore, simple
translocation of PI(4,5)P2 between membrane domains would
represent a rapid way to regulate lipid signaling throughout infec-
tion. Ca2 is a downstream effector of PI(4,5)P2 and accumulates
upon hydrolysis of PI(4,5)P2 to IP3 and DAG. Since we also ob-
served an increase in the intracellular Ca2 level upon cholesterol
treatment, it is also possible that there is rapid hydrolysis and
synthesis of PI(4,5)P2 in rafts, which would maintain the apparent
constant total cellular level of this lipid. In other systems, in addi-
tion to PLCD1 (42), enzymes that synthesize PI(4,5)P2, such as
phosphatidylinositol-4-phosphate-5-kinase (PIP5K), are also re-
cruited to rafts upon stimulation (44, 45). Thus, it is conceivable
that rapid turnover of PI(4,5)P2 could occur in rafts.
We cannot rule out the possibility that it is actually the rise in
intracellular Ca2 that induces segregation of PI(4,5)P2 into rafts.
Using an in vitro lipid monolayer system, Levental et al. (46)
showed that the lateral organization of PI(4,5)P2 is sensitive to
small changes in Ca2 concentration. However, it is not known if
Ca2 can influence the submembrane distribution of PI(4,5)P2 in
vivo. Regardless of whether there is a Ca2-dependent step, the
outcome of exposure of trophozoites to cholesterol is enrichment
of PI(4,5)P2 in lipid rafts. This provides significant insight into
signaling in this parasite.
In the present study, we demonstrated that PI(4,5)P2 uni-
formly decorates the plasma membrane of this parasite. We also
showed that in polarized cells, both lipid rafts and the constituent
signaling lipid, PI(4,5)P2, localize to the uroids. In mammalian
cells, there is increasing evidence that lipid rafts play a vital role in
delivering signaling molecules to uroids during cell migration. For
example, Millán et al. (40) showed that the uroids of polarized T
lymphocytes are enriched in cholesterol and disruption of rafts
leads to loss of uroids and subsequent inhibition of cell migration.
Furthermore, segregation of membrane proteins to uroids and
pseudopods is inhibited by disruption of lipid rafts in T lympho-
cytes (40, 47) and neutrophils (21). Another study of polarized
neutrophils revealed that DiIC16-stained raft fractions progress
from a uniform distribution to discrete patches that coalesce at
FIG 9 Exposure to cholesterol increases intracellular Ca2 levels in E. histolytica. Trophozoites were serum starved and exposed to cholesterol at concentrations
of 0 (control) to 3 mg/ml for either 60 or 15 min. Intracellular Ca2 levels were measured after treatment over a 35-min time interval. Intracellular Ca2 levels
at the 35-min time point for the untreated control cells were arbitrarily set equal to 100%, and the values at the other time points were reported as a percentage
of this final value. The data are the means SDs for3 independent experiments. (A) Sixty minutes of pretreatment with 0.75 or 3 mg/ml cholesterol resulted
in a significant increase in the intracellular Ca2 level compared to that for untreated controls (*, P 0.5; **, P 0.01; ***, P 0.001). (B) Similarly, an increase
in intracellular Ca2 levels was observed with a 15-min cholesterol pretreatment (*, P 0.5).
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uroids to form caps (48). Furthermore, cap formation in these
cells relies on the interaction of transmembrane proteins of the
DRM with both the lipids of the DRM and the proteins of the
actomyosin cytoskeleton (48). Since we observed the localization
of lipid rafts and PI(4,5)P2 in uroids and in ConA-positive, later-
ally localized membrane patches, it is possible that a similar lipid
raft-mediated delivery of PI(4,5)P2 to uroids occurs in E. histo-
lytica. Another mechanism by which PI(4,5)P2 could become en-
riched in uroids is by local synthesis. A number of reports in other
systems have shown that key PI(4,5)P2-synthesizing enzymes also
localize to uroids (49–52). However, whether these enzymes local-
ize to uroids of E. histolytica remains to be determined.
PI(4,5)P2 can function as a second messenger and bind various
actin-binding proteins. A proteomic analysis of E. histolytica
uroids identified the presence of actin-binding proteins that have
been reported to interact with PI(4,5)P2 in other eukaryotic cells,
including the spectrin-family proteins (e.g., filamin 2, an actinin-
like protein) and a novel protein, filopodin (53). In other systems,
PI(4,5)P2 has been shown to regulate actin cytoskeleton by bind-
ing and modulating filamin (54) and 	-actinin (55). Filopodin is
an ezrin-radixin-moesin (ERM) domain-containing protein.
Members of the ERM family bind PI(4,5)P2 and are known to
regulate uroid formation in T cells (56). Thus, PI(4,5)P2 may serve
as a bridge at the uroid, connecting the cytoskeleton to the plasma
membrane through various actin-binding proteins.
PI(4,5)P2 can also generate a variety of secondary messenger
molecules. For instance, at the leading edge of Dictyostelium dis-
coideum cells, PI(4,5)P2 is converted to PI(3,4,5)P3 by PI3K;
PI(3,4,5)P3 binds to and recruits several proteins to promote
pseudopod formation (reviewed in reference 52). Likewise,
PI(3,4,5)P3 localizes to pseudopods of motile E. histolytica (5). At
the trailing edge of mammalian cells, hydrolysis of PI(4,5)P2 to
DAG, which activates PKC, is essential for T cell chemotaxis (57).
IP3, another product of PI(4,5)P2 hydrolysis, stimulates an in-
crease in intracellular Ca2 levels, and increases in Ca2 correlate
with enhanced motility in neutrophils (58, 59). Ca2 is a potent
stimulator of motility through activation of myosin light-chain
kinase (MLCK), leading to an increase in myosin II-based con-
tractility at the uroid (60). In the current study, an increase in
intracellular Ca2 was accompanied by a robust augmentation of
motility after exposure to cholesterol. Thus, a similarly potent
PI(4,5)P2 to Ca
2 to MLCK system may exist in this pathogen. In
support of this, myosin II is found to localize to the uroids of E.
histolytica (2).
On average, we observed a modest increase in PI(4,5)P2 levels
in rafts after treatment with 0.05 mg/ml cholesterol, but there was
no difference in the total PI(4,5)P2 levels in the DRM. One expla-
nation for observing a statistically significant increase in motility
after treatment with the same concentration of cholesterol could
be that motility is very sensitive to the submembrane position of
PI(4,5)P2 and even small increases in PI(4,5)P2 in rafts can cause
enhanced cell movement. Our observation that an increase in
PI(4,5)P2 in rafts and uroids is accompanied by increases in intra-
cellular Ca2 and motility is suggestive of raft-mediated signaling
from PI(4,5)P2. However, it remains to be seen if the effect of
PI(4,5)P2 on motility after exposure to cholesterol is direct or
indirect. One way to test this would be to generate E. histolytica
cells with reduced levels of enzymes that are responsible for
PI(4,5)P2 synthesis (e.g., by knockdown of PIP5K). In E. histo-
lytica, these enzymes have not yet been definitively identified. Ge-
nome data suggest the existence of a putative E. histolytica PIP5K
gene (GI:67481998), and a BLASTP analysis of the translated pro-
tein sequence revealed a 41% identity to human phosphatidylino-
sitol-4-phosphate-5-kinase type 1. However, it remains to be
seen if this an authentic PI(4,5)P2-synthesizing enzyme.
Cholesterol is a major constituent of the eukaryotic plasma
membrane (61). Aley et al. (62) demonstrated that E. histolytica
possesses a high plasma membrane content of cholesterol, with a
cholesterol/phospholipid molar ratio of 0.87. There are intriguing
correlations between E. histolytica virulence and cholesterol. For
example, cholesterol has been shown to enhance virulence func-
tions in E. histolytica, including adhesion (27, 28), expression of
ConA binding sites on the cell surface (63), and hemolytic and
erythrophagocytic activity (64). Several studies have demon-
strated that it is possible to revive the virulence of avirulent E.
histolytica strains by supplying medium with cholesterol (65, 66)
or by repeated passage through liver, which is a major site of cho-
lesterol synthesis (67). Finally, long-term culture of E. histolytica
in medium supplemented with liposomes carrying phosphatidyl-
choline and cholesterol can preserve virulence (63). Our study is
the first to show that cholesterol impacts the submembrane and
subcellular localization of PI(4,5)P2 in E. histolytica and could be
key to unraveling the molecular mechanism by which cholesterol
regulates virulence.
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